Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ShRNA screening analysis of breast cancer

ABSTRACT: shRNA screening analysis of breast cancer

PROVIDER: PRJNA453539 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR7062990.fastq.gz	Fastqsanger.gz
	SRR7063000.fastq.gz	Fastqsanger.gz
	SRR7063010.fastq.gz	Fastqsanger.gz
	SRR7062991.fastq.gz	Fastqsanger.gz
	SRR7063001.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 24

Similar Datasets

shRNA screening analysis of breast cancer

Project description:Background: We searched triple negative breast cancer (TNBC) specifically expressing candidates for target therapy. Methods: High expressing genes in three TNBC cell lines compared to three non-TNBC cell lines were evaluated by using RNA sequencing (log2 ratio>5, q<0.05). By integrating the shRNA library screening and public gene expression databases, we identifyied candidates for therapeutic targets. The expression significance of the candidates was examined by using immunohistochemistry of 248 clinical breast cancer patients. Results: One hundred seventy one genes were detected as highly expressed genes in TNBC cell lines than non-TNBC cell lines, and 13 genes were picked up as candidates not expressing in non-cancerous tissues. Integrated analysis with shRNA screening identified three candidates as TBNC specific molecular targets. Protein staining were stronger in breast cancer tissues, especially TNBC, than in the normal tissues.

2019-02-27 | GSE113651 | GEO

RNA-seq analysis and shRNA screen of breast cancer

Project description:RNA-seq analysis and shRNA screen of breast cancer

| PRJNA453532 | ENA

Expression data from human breast cancer cell MDA-MB-231 stably expressing MYOSIN10 shRNA versus scramble shRNA

Project description:We used MYOSIN10 shRNA to stably silence the expression of endogenous MYOSIN10 in Breast cancer cell MDA-MB-231. To investigate the inner change of cells with silenced MYOSIN10, we conducted a genome-wide screening for all potential genes affected by MYOSIN10 shRNA using Affymetrix Human Genome U133 plus 2.0 array. We showed genes affected by MYOSIN10 knockdown in breast cancer cell MDA-MB-231

2020-12-31 | GSE52828 | GEO

RNA-seq analysis of breast cancer

2019-02-27 | GSE113650 | GEO

E-GEOD-45581

Project description:Expression Analysis of Microdissected Inflammatory Breast Cancer

2025-01-24 | E-GEOD-45581 | ExpressionAtlas

E-PROT-149

Project description:DIA-MS analysis of 21 breast cancer tissues

2024-06-05 | E-PROT-149 | ExpressionAtlas

Small RNA sequencing of exosomes in breast cancer screening population

Project description:The breast cancer screening population was selected for small RNA sequencing of plasma exosomes, one of several types of extracellular vesicles. The analysis included 728 piRNAs, 2656 miRNAs, and 154 tsRNAs.

2024-10-28 | GSE270497 | GEO

Transcriptome analysis of QPRT silencing in breast cancer cells

Project description:We identified quinolinate phosphoribosyltransferase (QPRT) as a prognostic factor in breast cancer. Transcription profiling analysis was performed in breast cancer cells transfected with control or QPRT shRNA.

2020-06-01 | GSE151521 | GEO

TRPM7 maintains mesenchymal phenotype of breast cancer cells by tensional regulation of SOX4 (SOX4 shRNA)

Project description:Analysis of the effect of shRNA-mediated knockdown of SOX4 on global gene expression levels in MDA-MB-231 human breast cancer cells. Results were used for the identification of overlapping up- and downregulated genes in TRPM7 + SOX4 shRNA MDA-MB-231 cells

2015-06-16 | GSE63957 | GEO

shRNA profiling of human normal breast and breast cancer cell lines to identify genes regulated by YAP

Project description:Frequent loss of heterozygosity (LOH) at 11q22-23 in breast cancer strongly suggests that this region contains a tumor suppressor gene, yet to be identified. We and others have shown Yes-associated protein (YAP), which is located at 11q22.2, transactivates the p53 family member p73 upon DNA damage, suggesting a tumor suppressive function for YAP. Our analysis of breast tumor tissues by immunohistochemistry (IHC) showed loss of YAP protein expression in great portion of breast cancers. We used microarray to look at the targte genes regulated by YAP in normal breast luminal cell and breast cancer cell lines. Experiment Overall Design: We generated stable cell lines by introducing control vector(pRS-IRES-GFP/pmig) or YAP shRNA(pRS-IRES-GFP-YAP/pmig-YAP) in a normal breast luminal cell line 1089 luminal and breast cancer cell lines MDA MB231. RAN was extracted and hybridized on Affymetrix microarrays.We looked for new target genes regulated by YAP in normal breast luminal cell and breast cancer cell lines.

2009-01-18 | E-GEOD-7700 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data